• These guidelines are developed with the intention of improving the outcomes of infectious disease by early and appropriate antimicrobial therapy while minimizing the emergence of resistance to antimicrobial agents.
  • Antimicrobial regimes given here are intended to be used for prophylactic or empirical therapy. Antimicrobial agents should be tailored whenever a microbiological diagnosis and antibiotic susceptibility results are available.
  • Specimens for cultures and other investigations for an early microbiological diagnosis should be obtained before commencing empirical therapy whenever possible.
  • Treatment options have been selected for the optimal use of antimicrobials in the country and may not include all therapeutic options available globally for a given infection.
  • Antimicrobial doses given are for adults with average build and normal renal function unless otherwise specified.
  • The main focus of these guidelines has been the common bacterial infections and the scope does not include a comprehensive range of infections caused by uncommon bacteria, viruses and fungal agents.
  • These guidelines are not intended to serve as complete management guidelines for infectious diseases since other aspects of management of infections are not covered here.
  • Best practices in antimicrobial therapy will continue to change with improving evidence base on infections and the guidelines will have to be revised accordingly in future.

Author: Roshan ( Web Admin )